Aktis Oncology, Inc.
AKTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $0 | $0 | $0 |
| - Cash | $37 | $30 | $129 |
| + Debt | $12 | $13 | $2 |
| Enterprise Value | -$25 | -$16 | -$127 |
| Revenue | $1 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $1 | $0 | $0 |
| % Margin | 100% | – | – |
| EBITDA | -$50 | -$34 | -$19 |
| % Margin | -3,394.4% | – | – |
| Net Income | -$44 | -$29 | -$18 |
| % Margin | -2,957.6% | – | – |
| EPS Diluted | 0 | 0 | 0 |
| % Growth | – | – | – |
| Operating Cash Flow | $15 | -$30 | -$18 |
| Capital Expenditures | -$3 | -$4 | -$2 |
| Free Cash Flow | $12 | -$34 | -$20 |